Both in Biotechnology
Replimune Group vs BioCryst Pharmaceuticals
Over the past year REPL returned +121.9% and BCRX returned +24.9%; their daily moves had a correlation of 0.06.
REPL +121.9% BCRX +24.9%Growth of $1, one year, split-adjusted
| Metric | REPL | BCRX |
|---|---|---|
| Price | $20.65 | $8.57 |
| Market cap | $1.96B | $2.19B |
| Today | +5.95% | +3.94% |
| 1 month | +57.0% | +5.8% |
| 6 months | +619.5% | −5.1% |
| Year to date | +112.4% | +9.9% |
| 1 year | — | +17.1% |
| Revenue growth (YoY) | — | +33.6% |
| Gross margin | — | 98.2% |
| Net margin | — | 35.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.3× |
| Net cash | $183.7M | -$471.6M |
| Dividend yield | — | — |
| Volatility (60d) | 77.7% | 44.9% |
| Short % of float | 29.6% | 10.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).